http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005038017-A8

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d2346330555e5cfdfaec02fef73031a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f3ebf63d28f804e0a154cf8da0ccf2c6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d7bf7c20de09dc9918e49f9c9b5da208
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_67d103af3a0f24624804f19d66bbc20e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0012
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-435
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-61
filingDate 2004-09-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9350102ba9838ffc597c48bbb0e2302e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a171de7d6c88ac9da47f8dc81425857d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_61ce3fbcb13e9e4f4151f0cf25a7e057
publicationDate 2005-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2005038017-A8
titleOfInvention Prevention of incorporation of non-standard amino acids into protein
abstract The instant invention is drawn to the methods and compositions necessary to provide recombinant proteins with a substantially reduced or eliminated content of norleucine or other non-standard amino acids. Various embodiments of the invention provide for the substantial elimination of the incorporation of non-standard amino acids into recombinant proteins by the co-expression or enhanced expression of a protein (or the enzymatically active portion thereof) capable of degrading norleucine or other non-standard amino acids, including norvaline, beta-methylnorleucine, and homoisoleucine. In certain particular embodiments of the invention, the norleucine is degraded by a glutamate dehydrogenase, a leucine dehydrogenase, a valine dehydrogenase, a phenylalanine dehydrogenase, a glutamate/leucine/phenylalanine/valine dehydrogenase, or an opine dehydrogenase. Also provided are the cells and DNA constructs for carrying out these methods.
priorityDate 2003-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID192784
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54017692
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID521918
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399600
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65098
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415861757
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9475
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33032
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399601
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP54531
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419565385
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ53560
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ44297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227976419
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415870843
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6991974
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0A393
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0A392
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID168760
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227976420
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21236
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419482979
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ60030
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP13154

Total number of triples: 47.